11/12/2018
FDA grants fast track designation to ONC201 for the treatment of Adult Recurrent H3 K27M-mutant High-Grade Glioma
10/18/2018
Spring Mountain Capital hosts presentation on artificial intelligence & robotics by Dr. Henrik Christensen
9/26/2018
Maven raises $27 million in Series B funding led by Sequoia Capital and Oak HC/FT
8/7/2018
RiskSense raises $12MM in Series B funding round co-led by Spring Mountain Capital and NightDragon Security
6/22/2018
Utz Quality Foods treats employees with Activate Healthcare onsite healthcare clinic
6/13/2018
Doctor.com recognized by Google as the only Google My Business (GMB) partner focused on healthcare
6/12/2018
IsoPlexis collaborates with Kite Pharma to publish clinical data in Blood highlighting the potential to predict which cancer patients will respond to CAR-T cell therapy
Vergent Bioscience raises $8.7 million in Series A financing led by Spring Mountain Capital
5/14/2018
IsoPlexis named as a top 10 analytics solution provider by Pharma Tech Outlook
5/07/2018
ReNetX Bio closes financing with Spring Mountain Capital
5/04/2018
OpenSlate’s Mike Henry discusses importance of brand safety with Bloomberg
4/09/2018
State of Arizona selects the RiskSense platform to monitor and manage cyber security risk
3/31/2018
Maven named as a top female-founded startup that is expected to take off in 2018
3/20/2018
Home Captain closes Series A financing with Spring Mountain Capital
3/15/2018
Spring Mountain Capital leads $8 million Series B financing in 180 Health Partners
3/14/2018
Maven Clinic announces new partnership with Castlight Health to offer comprehensive parental support platform to customers
1/31/2018
ONC201 trial begins at NYU for children with H3 K27M mutant glioma
1/05/2018
Maven’s Kate Ryder forecasts what will happen in women’s health in 2018 in Forbes
1/03/2018
Doctor.com’s David Murray shares his secrets to building great company culture in Forbes
12/13/2017
Doctor.com and Connect Healthcare announce merger to deliver the only complete solution to power the digital patient journey
12/11/2017
IsoPlexis wins 2017 Fierce Technology Innovation Award
12/01/2017
The Scientist names IsoPlexis technology the top innovation of 2017
11/15/2017
IsoPlexis receives $5.6 million in NIH funding to develop next-generation single-cell assay products, technologies and applications
10/24/2017
Maven’s Katherine Ryder shares her venture capital insights
10/23/2017
IsoPlexis receives $1.8M National Cancer Institute grant
10/13/2017
New Maven report: Why Investing in Return-to-Work Benefits is a Billion Dollar Opportunity for Companies
9/7/2017
Ad firms enlist OpenSlate to make sure ads run with “safe” YouTube videos
8/15/2017
Doctor.com launches the first universal “Web-Wide” online scheduling solution for healthcare providers
7/25/2017
Spring Mountain Capital leads $10.8 million Series A in digital health company Maven
Maven lands $11 million Series A to disrupt women’s health care
5/25/2017
Doctor.com and Healthgrades partner to help healthcare providers manage their online presence
5/8/2017
SimpleReach announces $13 million in funding, names MarTech veteran Hal Muchnick CEO
4/3/2017
IsoPlexis collaboration offers breakthrough insights into detecting and predicting patient response to T-cell therapy
2/23/2017
Doctor.com closes $5 million Series A financing led by Spring Mountain Capital
11/28/2016
Spring Mountain Capital completes successful exit of Prevalent to Insight Venture Partners
8/9/2016
ONC201 leads Oncoceutics to new imipridone class of cancer drugs
6/27/2016
Spring Mountain Capital’s Launny Steffens delivers the keynote speech to investors at the Amsterdam Private Equity Club (APEC) in the Netherlands
3/14/2016
Hurel providing cell-based models to EPA’s TOXCAST program
2/24/2016
U.S. patent issued for ONC201 composition of matter
2/16/2016
Science Signaling companion articles describe ONC201 mechanism of action
1/19/2016
Prevalent launches Legal Vendor Network
1/11/2016
Spring Mountain Capital leads $8 million Series B financing in Prevalent
11/6/2015
IsoPlexis appoints academic and industry experts to inaugural scientific advisory board
10/22/2015
Outrigger’s OpenSlate data shows a surge in ad-supported YouTube channels
10/6/2015
Spring Mountain Capital leads Series A financing for Oncoceutics
7/21/2015
Ziften announces general availability of Ziften v4.5
7/15/2015
Spring Mountain Capital leads $24 million investment in Ziften
7/9/2015
Oncoceutics announces completion of ONC201 first-in-man study
6/29/2015
Spring Mountain Capital leads new round of financing in Activate Healthcare
5/18/2015
Giga-tronics finalizes $10.0 Million order for high-performance YIG tuned filter products
5/13/2015
Giga-tronics receives $3.0 Million order for high-performance YIG tuned filter products
5/5/2015
Oncoceutics announces publication of a research article in the journal Molecular Cancer that describes the discovery of ONC201 as a selective anti-cancer agent
4/28/2015
Disney’s Maker Studios partners with Outrigger Media to sell ads across all of YouTube
Maker Studios partners with Outrigger’s OpenSlate to enable advertisers to purchase ad space on all YouTube channels
4/20/2015
Optivia Biotechnology forms technology & marketing alliance with Hurel Corporation
3/31/2015
Oncoceutics selected to present at the 106th Annual Meeting of the American Association for Cancer Research
Oncoceutics awarded NCI grant for clinical trial of ONC201 in glioblastoma multiforme
3/5/2015
Experimental cancer drug from Oncoceutics could be fast-tracked, says exec
3/3/2015
Phase I trials begin on Oncoceutics’ ONC201 at Rutgers Cancer Institute of New Jersey
3/2/2015
Giga-tronics announces a $1.6M strategic investment by AVI Partners, LLC and regains compliance with Nasdaq listing requirements
2/25/2015
An article in the journal Cancer Research indicates that Oncoceutics’ ONC201 eradicates cancer stem cells in colorectal cancer
1/13/2015
Outrigger Media raises $5.2 Million, adds YouTube demographics to OpenSlate
12/23/2014
Trimble acquires IRON Solutions to broaden its connected farm solution for growers, Ag dealers and agronomists
10/1/2014
ACEA Biosciences and Hurel Corporation announce joint marketing of integrated product kits
9/29/2014
Spring Mountain Capital leads investment in Oncoceutics
9/24/2014
Hurel Corporation completes investment from Johnston Associates, Inc.
9/3/2014
Spring Mountain Capital leads investment in Activate Healthcare
8/5/2014
Spring Mountain Capital leads investment in IsoPlexis Corporation
4/7/2014
Spring Mountain Capital’s Jamie Weston discusses Giga-tronics and American Power Group in an interview about private equity investing with thestreet.com
2/6/2014
The December/January issue of Buyout Magazine, in a cover story titled, “Deal-making sluggish as giants move down-market,” quotes Spring Mountain Capital’s Jamie Weston regarding growth-related opportunities in private equity (subscription required)
The HFMWeek article, “Exclusive: Spring Mountain to launch long/short equity FoHF,” breaks the news that Spring Mountain Capital is launching a dedicated long/short equity fund of hedge funds (subscription required)
10/29/2013
Cisco completes acquisition of WhipTail
10/1/2013
Hurel enters into cell-based R&D collaboration with Sanofi US to validate HurelHuman in vitro liver tissue co-culture for use in pre-clinical drug development
9/10/2013
Cisco announces intent to acquire WhipTail for $415 million
7/16/2013
Hurel Corporation launches cell-based in vitro testing product suite, milestone in movement away from use of live animals in drug and toxicity testing
4/3/2013
Hurel receives $9.2 Million Series A funding from Spring Mountain Capital
